-
Experts tend to focus on the kinds of foods you can eat to improve your health. But the speed at which you devour your dinner matters just as much.
-
Many employers and insurers are scaling back coverage and Medicare doesn’t cover the drugs for obesity. Meantime, some big employers are adding coverage, but their commitment isn’t guaranteed.
-
A new study finds that three quarters of American adults and half of adolescents are too heavy. That's making more of us sick and creating enormous health care costs.
-
Some Trump insiders are ready to take on the food industry. It remains to be seen whether their entree will result in any meaningful change in government oversight of “Big Food” — or in American health.
-
Will you still carry this added weight on New Year's Day 2026? For a quarter of us, that is probably going to prove true, according to a survey.
-
Although obesity remains one of our most pressing global health concerns, new research reveals an interesting twist.
-
Most people taking drugs like Ozempic and Wegovy have shed significant pounds. But obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust results with the medications.
-
After developing Type 2 diabetes and having a heart attack in his 40s, Clearwater resident Fabricio Zambrano switched to a plant-based lifestyle.
-
A report shows that obesity and overweight residents cost Florida $30.1 billion in 2022. Randall Croom, a Stetson management associate professor, says that’s taking a toll on our workforce and more.
-
Cheaper versions of Wegovy and Zepbound touted on social media could be fleeting. Copies are legal now because the brand-name drugs are in short supply. But the drugmakers are boosting production.